Emcure Prescribed drugs IPO: Itemizing debut hits ₹1,325 per share
Emcure Prescribed drugs Ltd made a strong entry into the inventory markets, surpassing expectations with important itemizing good points at ₹1,325 per share. This interprets to a substantial 31.45% acquire over its subject worth of ₹1,008. In accordance with Prashanth Tapse, Senior VP (Analysis) at Mehta Equities Ltd, the IPO noticed enthusiastic participation from various … Read more